GALMED PHARMACEUTICALS LTD. Deferred Tax Assets, Operating Loss Carryforwards
GALMED PHARMACEUTICALS LTD. (GLMD) had Deferred Tax Assets, Operating Loss Carryforwards of $43.04 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $43.04M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $36.76M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $43.04M 20-F · filed 2026-03-31 |
| 2024-12-31 | $36.76M 20-F · filed 2026-03-31 |